Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation.

Jensen G, Tao R, Eng C, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Koay E, Taniguchi C, Krishnan S, Das P.

Adv Radiat Oncol. 2018 Jul 17;3(4):595-600. doi: 10.1016/j.adro.2018.07.003. eCollection 2018 Oct-Dec.

2.

Urgent Management of Obstructing Colorectal Cancer: Divert, Stent, or Resect?

Malakorn S, Stein SL, Lee JH, You YN.

J Gastrointest Surg. 2018 Oct 3. doi: 10.1007/s11605-018-3990-8. [Epub ahead of print]

PMID:
30284201
3.

Surgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival.

Lillemoe HA, Kawaguchi Y, Passot G, Karagkounis G, Simoneau E, You YN, Mehran RJ, Chun YS, Tzeng CD, Aloia TA, Vauthey JN.

J Gastrointest Surg. 2018 Aug 6. doi: 10.1007/s11605-018-3890-y. [Epub ahead of print]

PMID:
30084064
4.

Physical activity and the risk of colorectal cancer in Lynch syndrome.

Dashti SG, Win AK, Hardikar SS, Glombicki SE, Mallenahalli S, Thirumurthi S, Peterson SK, You YN, Buchanan DD, Figueiredo JC, Campbell PT, Gallinger S, Newcomb PA, Potter JD, Lindor NM, Le Marchand L, Haile RW, Hopper JL, Jenkins MA, Basen-Engquist KM, Lynch PM, Pande M.

Int J Cancer. 2018 Nov 1;143(9):2250-2260. doi: 10.1002/ijc.31611. Epub 2018 Aug 7.

PMID:
29904935
5.

Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.

Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, You YN, Kozower BD, Greenberg CC, Schrag D, Venook A, McKellar D, Winchester DP, Chang GJ; Alliance for Clinical Trials in Oncology Network Cancer Surveillance Optimization Working Group.

JAMA. 2018 May 22;319(20):2104-2115. doi: 10.1001/jama.2018.5816.

PMID:
29800181
6.

Nongastrointestinal Stromal Tumor Spindle Cell Sarcomas of the Colon or Rectum.

Ikoma N, Roland CL, Cormier JN, Chiang YJ, Torres KE, Hunt KK, You YN, Feig BW.

Am Surg. 2018 Apr 1;84(4):570-575.

PMID:
29712608
7.

Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.

Chang K, Taggart MW, Reyes-Uribe L, Borras E, Riquelme E, Barnett RM, Leoni G, San Lucas FA, Catanese MT, Mori F, Diodoro MG, You YN, Hawk ET, Roszik J, Scheet P, Kopetz S, Nicosia A, Scarselli E, Lynch PM, McAllister F, Vilar E.

JAMA Oncol. 2018 Aug 1;4(8):1085-1092. doi: 10.1001/jamaoncol.2018.1482.

PMID:
29710228
8.
9.

Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma.

Holliday EB, Hunt A, You YN, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Eng C, Koay EJ, Minsky BD, Taniguchi C, Krishnan S, Herman JM, Das P.

J Gastrointest Oncol. 2017 Dec;8(6):990-997. doi: 10.21037/jgo.2017.09.02.

10.

Clinical features and survival of gastric cancer patients with DNA mismatch repair deficiency.

Ikoma N, Cloyd J, Badgwell BD, Agnes A, Rodriguez-Bigas M, Ajani JA, You YN.

J Surg Oncol. 2018 Mar;117(4):707-709. doi: 10.1002/jso.24926. Epub 2017 Dec 11.

PMID:
29228462
11.

Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial.

Bednarski BK, Slack RS, Katz M, You YN, Papadopolous J, Rodriguez-Bigas MA, Skibber JM, Matin SF, Chang GJ.

Dis Colon Rectum. 2018 Jan;61(1):77-83. doi: 10.1097/DCR.0000000000000945.

PMID:
29215474
12.

Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis.

Gunther JR, Chadha AS, Shin US, Park IJ, Kattepogu KV, Grant JD, Weksberg DC, Eng C, Kopetz SE, Das P, Delclos ME, Kaur H, Maru DM, Skibber JM, Rodriguez-Bigas MA, You YN, Krishnan S, Chang GJ.

Adv Radiat Oncol. 2017 Apr 12;2(3):455-464. doi: 10.1016/j.adro.2017.04.001. eCollection 2017 Jul-Sep.

13.

Why is surgeon qualification important for clinical trials, and how can it be achieved?

Kurtzman SH, Boughey JC, You YN.

Bull Am Coll Surg. 2016 Sep;101(9):51-2. No abstract available.

PMID:
28941372
14.

NRG GI002: Moving the needle toward TNT in locally advanced rectal cancer.

George TJ Jr, Wu C, You YN.

Bull Am Coll Surg. 2016 Oct;101(10):61-2. No abstract available.

PMID:
28937723
15.

Improving rectal cancer outcomes through advocacy, education, and research: The OSTRiCh Consortium and the new NAPRC.

Monson JRT, Dietz DW, Boughey JC, You YN.

Bull Am Coll Surg. 2016 Nov;101(11):45-6. No abstract available.

PMID:
28937195
16.

Individualized Treatment Sequencing Selection Contributes to Optimized Survival in Patients with Rectal Cancer and Synchronous Liver Metastases.

Conrad C, Vauthey JN, Masayuki O, Sheth RA, Yamashita S, Passot G, Bailey CE, Zorzi D, Kopetz S, Aloia TA, You YN.

Ann Surg Oncol. 2017 Dec;24(13):3857-3864. doi: 10.1245/s10434-017-6089-7. Epub 2017 Sep 19.

PMID:
28929463
17.

Assessing the quality of reports about randomized controlled trials of scalp acupuncture combined with another treatment for stroke.

You YN, Cho MR, Kim JH, Park JH, Park GC, Song MY, Choi JB, Han JY.

BMC Complement Altern Med. 2017 Sep 6;17(1):452. doi: 10.1186/s12906-017-1950-6.

18.

Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Patients With Pancreatic Ductal Adenocarcinoma.

Cloyd JM, Katz MHG, Wang H, Cuddy A, You YN.

JAMA Surg. 2017 Nov 1;152(11):1086-1088. doi: 10.1001/jamasurg.2017.2631. No abstract available.

19.

In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation.

Borras E, Chang K, Pande M, Cuddy A, Bosch JL, Bannon SA, Mork ME, Rodriguez-Bigas MA, Taggart MW, Lynch PM, You YN, Vilar E.

Cancer Prev Res (Phila). 2017 Oct;10(10):580-587. doi: 10.1158/1940-6207.CAPR-17-0058. Epub 2017 Aug 1.

20.

Accelerated enhanced Recovery following Minimally Invasive colorectal cancer surgery (RecoverMI): a study protocol for a novel randomised controlled trial.

Price BA, Bednarski BK, You YN, Manandhar M, Dean EM, Alawadi ZM, Bryce Speer B, Gottumukkala V, Weldon M, Massey RL, Wang X, Qiao W, Chang GJ.

BMJ Open. 2017 Jul 20;7(7):e015960. doi: 10.1136/bmjopen-2017-015960.

21.

Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer.

Ikoma N, You YN, Bednarski BK, Rodriguez-Bigas MA, Eng C, Das P, Kopetz S, Messick C, Skibber JM, Chang GJ.

J Clin Oncol. 2017 Aug 10;35(23):2631-2638. doi: 10.1200/JCO.2016.72.1464. Epub 2017 Jun 28.

22.

Mutational Heterogeneity in APC and KRAS Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal Tumorigenesis.

Gausachs M, Borras E, Chang K, Gonzalez S, Azuara D, Delgado Amador A, Lopez-Doriga A, San Lucas FA, Sanjuan X, Paules MJ, Taggart MW, Davies GE, Ehli EA, Fowler J, Moreno V, Pineda M, You YN, Lynch PM, Lazaro C, Navin NE, Scheet PA, Hawk ET, Capella G, Vilar E.

Clin Cancer Res. 2017 Oct 1;23(19):5936-5947. doi: 10.1158/1078-0432.CCR-17-0821. Epub 2017 Jun 23.

23.

Can Microsatellite Status of Colorectal Cancer Be Reliably Assessed after Neoadjuvant Therapy?

Goldstein JB, Wu W, Borras E, Masand G, Cuddy A, Mork ME, Bannon SA, Lynch PM, Rodriguez-Bigas M, Taggart MW, Wu J, Scheet P, Kopetz S, You YN, Vilar E.

Clin Cancer Res. 2017 Sep 1;23(17):5246-5254. doi: 10.1158/1078-0432.CCR-16-2994. Epub 2017 May 18.

24.

Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection.

You YN, Shiozaki H, Lee JE, Passot G, Goumard C, Okuno M, Aloia TA, Eng C, Chang G, Vauthey JN, Conrad C.

Ann Surg Oncol. 2017 Sep;24(9):2595. doi: 10.1245/s10434-017-5878-3. Epub 2017 May 16.

PMID:
28510798
25.

Assessing the quality of reports about randomized controlled trials of scalp acupuncture treatment for vascular dementia.

You YN, Cho MR, Park JH, Park GC, Song MY, Choi JB, Na CS, Han JY, Shin JC, Kim JH.

Trials. 2017 May 2;18(1):205. doi: 10.1186/s13063-017-1945-0.

26.

Three Different Approaches to the Inferior Mesenteric Artery during Robotic D3 Lymphadenectomy for Rectal Cancer.

Malakorn S, Sammour T, Bednarski B, You YN, Chang GJ.

Ann Surg Oncol. 2017 Jul;24(7):1923. doi: 10.1245/s10434-017-5792-8. Epub 2017 Feb 17.

PMID:
28213788
27.

Clinical Practice Guidelines for the Surgical Treatment of Patients With Lynch Syndrome.

Herzig DO, Buie WD, Weiser MR, You YN, Rafferty JF, Feingold D, Steele SR.

Dis Colon Rectum. 2017 Feb;60(2):137-143. doi: 10.1097/DCR.0000000000000785. No abstract available.

PMID:
28059909
28.

Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity.

Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P.

Radiother Oncol. 2017 Jan;122(1):146-151. doi: 10.1016/j.radonc.2016.12.015. Epub 2017 Jan 3.

PMID:
28057329
29.

Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome.

Mork ME, Rodriguez A, Taggart MW, Rodriguez-Bigas MA, Lynch PM, Bannon SA, You YN, Vilar E.

Fam Cancer. 2017 Jul;16(3):357-361. doi: 10.1007/s10689-016-9960-y.

30.

Oncological Outcomes After Robotic Proctectomy for Rectal Cancer: Analysis of a Prospective Database.

Sammour T, Malakorn S, Bednarski BK, Kaur H, Shin US, Messick C, You YN, Chang GJ.

Ann Surg. 2018 Mar;267(3):521-526. doi: 10.1097/SLA.0000000000002112.

PMID:
27997470
31.

Clinical and Economic Evaluation of Treatment Strategies for T1N0 Anal Canal Cancer.

Deshmukh AA, Zhao H, Das P, Chiao EY, You YN, Franzini L, Lairson DR, Swartz MD, Giordano SH, Cantor SB.

Am J Clin Oncol. 2018 Jul;41(7):626-631. doi: 10.1097/COC.0000000000000339.

PMID:
27755059
32.

Scalp acupuncture and electromagnetic convergence stimulation for patients with cerebral infarction: study protocol for a randomized controlled trial.

Han JY, Kim JH, Park JH, Song MY, Song MK, Kim DJ, You YN, Park GC, Choi JB, Cho MR, Shin JC, Cho JH.

Trials. 2016 Oct 11;17(1):490.

33.

Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer.

Alawadi Z, Phatak UR, Hu CY, Bailey CE, You YN, Kao LS, Massarweh NN, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ.

Cancer. 2017 Apr 1;123(7):1124-1133. doi: 10.1002/cncr.30230. Epub 2016 Aug 1.

34.

DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics.

de Rosa N, Rodriguez-Bigas MA, Chang GJ, Veerapong J, Borras E, Krishnan S, Bednarski B, Messick CA, Skibber JM, Feig BW, Lynch PM, Vilar E, You YN.

J Clin Oncol. 2016 Sep 1;34(25):3039-46. doi: 10.1200/JCO.2016.66.6826. Epub 2016 Jul 18.

35.

Genomic Landscape of Colorectal Mucosa and Adenomas.

Borras E, San Lucas FA, Chang K, Zhou R, Masand G, Fowler J, Mork ME, You YN, Taggart MW, McAllister F, Jones DA, Davies GE, Edelmann W, Ehli EA, Lynch PM, Hawk ET, Capella G, Scheet P, Vilar E.

Cancer Prev Res (Phila). 2016 Jun;9(6):417-27. doi: 10.1158/1940-6207.CAPR-16-0081. Epub 2016 May 24.

36.

Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy.

Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Das P, Eng C, Kopetz S, Wolff RA, Crane CH, Krishnan S, Minsky B, Hu CY, Nguyen S, Chang GJ.

Am J Clin Oncol. 2017 Jun;40(3):277-282. doi: 10.1097/COC.0000000000000150.

37.

Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency.

Mork ME, Borras E, Taggart MW, Cuddy A, Bannon SA, You YN, Lynch PM, Ramirez PT, Rodriguez-Bigas MA, Vilar E.

Fam Cancer. 2016 Oct;15(4):587-91. doi: 10.1007/s10689-016-9902-8.

38.

Impact of multimodal therapy in locally recurrent rectal cancer.

You YN, Skibber JM, Hu CY, Crane CH, Das P, Kopetz ES, Eng C, Feig BW, Rodriguez-Bigas MA, Chang GJ.

Br J Surg. 2016 May;103(6):753-762. doi: 10.1002/bjs.10079. Epub 2016 Mar 2.

39.

Reply to L.B. Saltz.

Mork ME, You YN, Vilar E.

J Clin Oncol. 2016 May 1;34(13):1560-1. doi: 10.1200/JCO.2015.66.2049. Epub 2016 Feb 29. No abstract available.

PMID:
26926688
40.

Rectal cancer resection: Laparoscopic or open--which way forward?.

Fleshman JW, Boughey JC, You YN.

Bull Am Coll Surg. 2016 Jan;101(1):64-6. No abstract available.

PMID:
26891508
41.

Prospective comparative effectiveness trial for malignant bowel obstruction: SWOG S1316.

Krouse RS, You YN.

Bull Am Coll Surg. 2015 Dec;100(12):49-50. No abstract available.

PMID:
26749971
42.

OsCYP21-4, a novel Golgi-resident cyclophilin, increases oxidative stress tolerance in rice.

Lee SS, Park HJ, Jung WY, Lee A, Yoon DH, You YN, Kim HS, Kim BG, Ahn JC, Cho HS.

Front Plant Sci. 2015 Oct 1;6:797. doi: 10.3389/fpls.2015.00797. eCollection 2015.

43.

PACES trial: Evaluating the effectiveness of eflornithine and sulindac in preventing colon adenomas.

Zell J, You YN, Boughey JC.

Bull Am Coll Surg. 2015 Aug;100(8):70-1. No abstract available.

PMID:
26419059
44.

Development and characterization of genic-SSR markers from different Asia lotus (Nelumbo nucifera) types by RNA-seq.

Zheng XF, You YN, Diao Y, Zheng XW, Xie KQ, Zhou MQ, Hu ZL, Wang YW.

Genet Mol Res. 2015 Sep 22;14(3):11171-84. doi: 10.4238/2015.September.22.11.

45.

Leaf transcriptome analysis and development of SSR markers in water chestnut (Eleocharis dulcis).

Liu HB, You YN, Zhu ZX, Zheng XF, Huang JB, Hu ZL, Diao Y.

Genet Mol Res. 2015 Jul 27;14(3):8314-25. doi: 10.4238/2015.July.27.20.

46.

Multimodality treatment considerations in esophageal and gastric cancer: Are we making progress?

Roses RE, Datta J, You YN, Boughey JC.

Bull Am Coll Surg. 2015 Jul;100(7):63-5. No abstract available.

PMID:
26248400
47.

High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer.

Mork ME, You YN, Ying J, Bannon SA, Lynch PM, Rodriguez-Bigas MA, Vilar E.

J Clin Oncol. 2015 Nov 1;33(31):3544-9. doi: 10.1200/JCO.2015.61.4503. Epub 2015 Jul 20.

48.

New manual for cancer surgery issued: Operative Standards for Cancer Surgery.

Martin LW, Veeramachaneni NK, Katz MH, You YN, Boughey JC, Nelson H, Hunt KK.

Bull Am Coll Surg. 2015 Jun;100(6):43-4. No abstract available.

PMID:
26182523
49.

A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer.

Dineen S, Lynch PM, Rodriguez-Bigas MA, Bannon S, Taggart M, Reeves C, Modaro C, Overman M, Chang GJ, Skibber JM, You YN.

J Natl Compr Canc Netw. 2015 Jul;13(7):865-72.

PMID:
26150580
50.

Limited resection as a cure for early lung cancer: time to challenge the gold standard?

Altorki N, Kohman LJ, Veit LJ, You YN, Boughey JC.

Bull Am Coll Surg. 2015 May;100(5):57-8. No abstract available.

PMID:
26031124

Supplemental Content

Support Center